Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SOL SpAMIL:SOL -0.65%74 Debt-to-EBITDA is 1.61 as of Dec. 2025, which is 6% below its 10-year median of 1.71. GuruFocus rates MIL:SOL with a GF Score™ of 74/100 and a GF Value™ of €42.65 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,234 Chemicals companies, SOL SpA ranks better than 57.94% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for SOL SpA's Debt-to-EBITDA or its related term are showing as below:
MIL:SOL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.39 Med: 1.71 Max: 2.07
Current: 1.64
During the past 13 years, the highest Debt-to-EBITDA Ratio of SOL SpA was 2.07. The lowest was 1.39. And the median was 1.71.
MIL:SOL's Debt-to-EBITDA is ranked better than 57.94% of 1234
companies
in the Chemicals industry
Industry Median: 2.155
vs MIL:SOL: 1.64
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
SOL SpA Debt-to-EBITDA Related Terms
SOL SpA Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for SOL SpA's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:SOL vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, SOL SpA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOL SpA Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SOL SpA's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SOL SpA's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
SOL SpA (MIL:SOL) has a Debt-to-EBITDA of 1.61 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on SOL SpA. This is near median its historical median of 1.71. Over the past decade, SOL SpA's Debt-to-EBITDA has ranged from 1.39 to 2.07. According to the industry distribution chart, SOL SpA ranks #519 out of 1234 companies in the Chemicals industry, placing it in the top 42.1%.
Is SOL SpA's Debt-to-EBITDA too high?
SOL SpA's current Debt-to-EBITDA of 1.61 is near median its 10-year median of 1.71. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 2.07. The Chemicals industry median Debt-to-EBITDA is 2.16. SOL SpA's value of 1.61 is 25.3% below this industry median. Based on the distribution chart, SOL SpA ranks #519 out of 1234 companies in the Chemicals industry, which is above the industry midpoint. Overall, SOL SpA has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOL SpA's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, SOL SpA ranks #519 out of 1234 companies for Debt-to-EBITDA. This puts SOL SpA in the upper half of its industry. The industry median Debt-to-EBITDA is 2.16. SOL SpA's value of 1.61 is 25.3% below this benchmark. Historically, SOL SpA's own Debt-to-EBITDA has ranged from 1.39 to 2.07 over the past decade. While the company's 10-year median is 1.71 vs. the industry median of 2.16, SOL SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,234 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOL SpA's current Debt-to-EBITDA of 1.61 is 25.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on SOL SpA. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOL SpA's current Debt-to-EBITDA is 1.61, which is near median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOL SpA stock overvalued right now?
Based on GuruFocus' analysis, SOL SpA (MIL:SOL) is currently considered Significantly Overvalued. The stock's GF Value™ is €42.65, compared to a current price of €61.60 — trading 44.4% above its estimated fair value. The current Debt-to-EBITDA is 1.61, which is near median its 10-year median of 1.71 and 25.3% below the Chemicals industry median of 2.16. SOL SpA's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For SOL SpA (MIL:SOL), the current Debt-to-EBITDA is 1.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOL SpA (MIL:SOL) Overvalued in 2026?
Based on GuruFocus' analysis, SOL SpA stock appears to be overvalued.
The current stock price of €61.60 is trading 44.4% above its estimated GF Value™ of €42.65.
GuruFocus considers SOL SpA to be Significantly Overvalued.
Key valuation signals for MIL:SOL:
Debt-to-EBITDA: 1.61 (near median its 10-year median of 1.71)
GF Value™: €42.65 vs. price of €61.60 (44.4% above fair value)
Industry Position: 25.3% below the Chemicals median (#519 of 1234)
No single metric tells the full story. See the MIL:SOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOL SpA manufactures and sells industrial gases and medical equipment. The firm's two segments are based on product type. The home-care segment, which generates the majority of revenue, sells a variety of medicinal gases including oxygen, nitrogen, nitrous oxide, carbon dioxide, synthetic air, and medical air. The segment also provides medical air services for hospitals. The technical gases segment sells gas-based products to the energy, agricultural, food, metalworking, glass, and electronics industries. More of SOL's revenue comes from Italy than any other country.
74GF Score
Get the complete analysis for MIL:SOL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SOL has been successfully added to your 
